Cancer BiologyCancersPeer-reviewed
A novel in-vitro model of the bone marrow microenvironment in AML identifies CD44 and Focal Adhesion Kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance
Eleni E Ladikou, K. Sharp, Fabio A. Simoes…·Andrea G. S. Pepper
This study identifies CD44 and FAK as therapeutic targets to reverse adhesion-mediated drug resistance in AML by developing an in-vitro BMME model and testing their synergistic effects.
4 citations